2,123
|
17450 |
P. aeruginosa infection, chronic
|
|
decreases_quantity of
|
type IV pilus
|
in patients with CF
|
17519 |
type IV pilus
|
|
increases_activity of
|
I-kappaB kinase/NF-kappaB signaling
|
|
17523 |
type IV pilus
|
|
increases_activity of
|
TLR2
|
|
17716 |
type IV pilus
|
|
increases_activity of
|
MAPK cascade
|
in P. aeruginosa infected host
|
17718 |
type IV pilus
|
|
increases_activity of
|
Ras protein signal transduction
|
in P. aeruginosa infected host
|
|
15695491
|
Pseudomonas aeruginosa diseases
|
2,620
|
24904 |
fimL
|
|
affects_activity of
|
type IV pilus-dependent motility
|
|
|
21264306
|
Pseudomonas aeruginosa diseases
|
2,621
|
24891 |
type IV pilus
|
|
increases_activity of
|
P. aeruginosa infection, acute
|
|
|
21264306
|
Pseudomonas aeruginosa diseases
|
2,783
|
25724 |
desB
|
|
affects_activity of
|
type IV pilus-dependent motility
|
|
|
21184216
|
Pseudomonas aeruginosa diseases
|
3,202
|
29418 |
vfr
|
|
increases_quantity of
|
type IV pilus
|
|
29442 |
Chp chemotaxis-like chemosensory system
|
|
affects_quantity of
|
type IV pilus
|
|
29443 |
Chp chemotaxis-like chemosensory system
|
|
affects_activity of
|
type IV pilus-dependent motility
|
|
|
22354680
|
Pseudomonas aeruginosa diseases
|
3,206
|
29545 |
rsmA
|
|
increases_quantity of
|
type IV pilus
|
|
29694 |
mucoid strain
|
|
decreases_quantity of
|
type IV pilus
|
|
|
22354680
|
Pseudomonas aeruginosa diseases
|
3,211
|
29655 |
rcsB
|
|
decreases_activity of
|
type IV pilus-dependent motility
|
if rcsB is overexpressed
|
|
19547710
|
Pseudomonas aeruginosa diseases
|
3,231
|
29786 |
type IV pilus
|
|
increases_activity of
|
biofilm formation
|
|
29942 |
CupD fimbriae assembly
|
|
decreases_activity of
|
type IV pilus-dependent motility
|
|
29944 |
pilD
|
|
increases_processing of
|
pilA
|
|
29946 |
pilA
|
|
increases_quantity of
|
type IV pilus
|
|
29954 |
rpoN
|
|
affects_expression of
|
pilA
|
|
29955 |
pilR
|
|
affects_expression of
|
pilA
|
|
29956 |
pilS
|
|
increases_activity of
|
pilR
|
|
29965 |
fimX
|
|
affects_activity of
|
type IV pilus-dependent motility
|
|
29972 |
pprA
|
|
increases_activity of
|
pprB
|
|
29977 |
pprB
|
|
increases_quantity of
|
type IVb pilus
|
|
29987 |
pilR
|
|
increases_quantity of
|
type IV pilus
|
|
|
21554516
|
Pseudomonas aeruginosa diseases
|
3,247
|
29958 |
algR
|
|
increases_activity of
|
type IV pilus-dependent motility
|
|
|
8790418
|
Pseudomonas aeruginosa diseases
|
3,359
|
30807 |
type IV pilus
|
|
interacts (colocalizes) with
|
N-glycan
|
at the apical surface of polarized epithelial cells and in vitro
|
30814 |
type IV pilus
|
|
increases_activity of
|
entry of bacterium into host cell
|
at the apical surface of polarized epithelial cells
|
30830 |
type IV pilus
|
|
increases_activity of
|
phosphatidylinositol 3-kinase signaling
|
at the apical surface of polarized epithelial cells
|
30834 |
type IV pilus
|
|
increases_activity of
|
protein kinase B signaling
|
at the apical surface of polarized epithelial cells
|
30840 |
type IV pilus
|
NOT |
affects_activity of
|
EGFR
|
at the apical surface of polarized epithelial cells
|
|
22496644
|
Pseudomonas aeruginosa diseases
|
3,361
|
30843 |
phosphatidylinositol 3-kinase signaling
|
|
increases_activity of
|
protein kinase B signaling
|
in MDCK cells
|
|
22496644
|
Pseudomonas aeruginosa diseases
|
3,903
|
39606 |
pprA
|
|
increases_activity of
|
pprB
|
|
39607 |
pprB
|
|
increases_quantity of
|
type IVb pilus
|
|
|
23209420
|
Pseudomonas aeruginosa diseases
|
4,467
|
45003 |
pilA
|
|
interacts (colocalizes) with
|
DYNLL1
|
|
|
24098557
|
Pseudomonas aeruginosa diseases
|